TY  - GEN
N2  - Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not met. Studies have shown that primary care providers (PCPs) overestimate how aggressive they are at titrating glucose-lowering therapy and that they underestimate how long their patients' HbA1c remain above goal. Early and more aggressive management of hyperglycemia reduces long term microvascular and macrovascular complications. Reducing therapeutic inertia leads to improved patient outcomes.  The primary aim of this quality improvement project was to decrease the percentage of patients age 18-75 years with HbA1c >9% who had no diabetic medication changes at their last visit by 10% at a primary care clinic in the Pacific Northwest.
DO  - 10.6083/kd17ct51t
DO  - DOI
AB  - Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not met. Studies have shown that primary care providers (PCPs) overestimate how aggressive they are at titrating glucose-lowering therapy and that they underestimate how long their patients' HbA1c remain above goal. Early and more aggressive management of hyperglycemia reduces long term microvascular and macrovascular complications. Reducing therapeutic inertia leads to improved patient outcomes.  The primary aim of this quality improvement project was to decrease the percentage of patients age 18-75 years with HbA1c >9% who had no diabetic medication changes at their last visit by 10% at a primary care clinic in the Pacific Northwest.
AD  - Oregon Health and Science University
T1  - Addressing therapeutic inertia in diabetes management: a quality improvement project
DA  - 2022
AU  - Corson, Anna
L1  - https://digitalcollections.ohsu.edu/record/9498/files/Corson.Anna.2022.pdf
PB  - Oregon Health and Science University
PY  - 2022
ID  - 9498
L4  - https://digitalcollections.ohsu.edu/record/9498/files/Corson.Anna.2022.pdf
KW  - Drug Therapy
KW  - Hypoglycemic Agents
KW  - Primary Health Care
KW  - Quality Improvement
KW  - Hyperglycemia
KW  - Diabetes Mellitus, Type 2
KW  - Glycated Hemoglobin
TI  - Addressing therapeutic inertia in diabetes management: a quality improvement project
Y1  - 2022
L2  - https://digitalcollections.ohsu.edu/record/9498/files/Corson.Anna.2022.pdf
LK  - https://digitalcollections.ohsu.edu/record/9498/files/Corson.Anna.2022.pdf
UR  - https://digitalcollections.ohsu.edu/record/9498/files/Corson.Anna.2022.pdf
ER  -